Skip to content

Evaluation of the safety and efficacy of extra-abdominal oblique muscle intercostal block combined with general anesthesia in laparoscopic cholecystectomy: a single-center, prospective, observational cohort study

Evaluation of the safety and efficacy of extra-abdominal oblique muscle intercostal block combined with general anesthesia in laparoscopic cholecystectomy: a single-center, prospective, observational cohort study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600128857
Enrollment
Unknown
Registered
2026-07-27
Start date
2026-08-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gall bladder stone, Cholecystitis

Interventions

Experimental group (EOIB combined with general anesthesia) :None
Control group (TAP block combined with general anesthesia):None

Sponsors

ZhangZhou Municipal Hospital of Fujian province
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Age 18–75 years, no gender restriction; 2. ASA I–III; 3. Intended to undergo laparoscopic cholecystectomy; 4. Understand and consent to participate in the study by signing a written informed consent form; 5. Able to comprehend and cooperate with postoperative pain scoring and scale assessments.

Exclusion criteria

Exclusion criteria: 1. Allergy to local anesthetics or study-related medications; 2. Uncontrolled infection at the puncture site, abdominal skin defect, or systemic infection; 3. Coagulation dysfunction (INR> 1.5 or platelet count <80×10?/L); 4. Severe cardiopulmonary or hepatic/renal dysfunction, chronic obstructive pulmonary disease; 5. History of chronic pain or use of opioid analgesics within 2 weeks prior to surgery; 6. Mental illness or cognitive impairment preventing cooperation with pain assessment; 7. Pregnant or breastfeeding women; 8. Other medical or non-medical conditions deemed by the investigator as unsuitable for participation in this study.

Design outcomes

Primary

MeasureTime frame
Postoperative 24-hour resting VSA;

Secondary

MeasureTime frame
Postoperative 24-hour dosage and utilization rate of rescue analgesics;Visual simulation scoring during the activity;Quick recovery indicators: time to first flatus postoperatively, time to first ambulation postoperatively, postoperative hospital stay duration;Duration of analgesia;Postoperative patient satisfaction score for analgesia;

Countries

China

Contacts

Public ContactJiang Liwei

ZhangZhou Municipal Hospital of Fujian province

1643953904@qq.com+86 596 6853885

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Aug 10, 2026